Kyle Nilson, PhD
Senior Field Application Scientist, QIAGEN Digital Insights
For >20 years, our curated knowledge has been the foundation of QIAGEN Ingenuity Pathway Analysis (IPA). Now, you can tap into these data outside of IPA with QIAGEN Biomedical KB-HD.
Discover the transformative role of knowledge graphs in predicting adverse outcomes and toxicity, understanding mechanisms of action and accelerating pharmaceutical R&D.
Venkatesh Moktali, PhD
Director, Global Product Manger, QIAGEN Digital Insights
Our Biomedical Knowledge Bases provide an unparalleled blend of expertly curated and AI-generated biomedical relationship data, enhancing both quality and volume.
Discover how these comprehensive resources empower you to bypass the extensive curation process and focus on extracting insights, accelerating the path to drug discovery
Joseph Pearson, PhD
Director, Global Product Manager, QIAGEN Digital Insights
Drug development often hits a critical bottleneck in the discovery phase: the time investment needed to find, gather, analyze and evaluate datasets to prioritize targets for the next stage.
Learn how deeply curated data unified across therapeutic areas can help you generate evidence-based insights for prioritizing candidates.
Perform full ‘omics analysis and deploy scalable analysis pipelines from a single platform.
Access millions of high-quality biomedical relationships to get your “Eureka!” moment faster.
